Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)
Meta-analysis / review
Abstract
This review summarises the emerging antitumour activities of bitter melon (Momordica charantia) and its proteins and triterpenoids against various cancers, complementing its well-known antidiabetic effects.
Referenced for these plants
How to cite
Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.